Alpha-1 antitrypsin deficiency (A1AD)
Alpha-1 Antitrypsin Deficiency A future NBS candidate?
... Condition: Alpha-1 antitrypsin deficiency, alpha-1 proteinase inhibitor deficiency, Alpha-1, AATD.. Alpha-1 antitrypsin: Protein that is potent serine proteinase inhibitor (SERPIN) and[r] ...
17
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
... Alpha 1 antitrypsin deficiency (AATD) is a hereditary genetic disorder characterized by low serum levels of alpha 1 protease inhibitor (A 1 -PI; also known as alpha ...
14
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
... Background: Alpha-1-antitrypsin (AAT) deficiency (AATD) of Z, Mmalton, Siiyama type is associated with liver storage of the mutant proteins and liver ...Siiyama ...
9
Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency
... [1-3]. Alpha-1 antitrypsin deficiency (A1ATD) is an estab- lished genetic risk factor estimated to occur in 1-2% of patients with COPD, though generally under-recognised and the ...
7
Alpha -1-antitrypsin deficiency, associated diseases and treatments: a review
... cirrhosis. Alpha 1-antitrypsin deficiency is heterogeneous genetic disorder due to mutation of chromosome no ...the deficiency of Alpha ...with alpha 1 ...
7
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
... Abstract: Alpha-1-antitrypsin deficiency (AATD), also known as alpha1-proteinase inhibitor deficiency, is an autosomal co-dominant ...dysfunctional ...
12
Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency
... Because alpha-1 antitrypsin deficiency (AATD) is a classical exclu- sion criterion in RCTs, there is no available data for ECT in ...multicenter 1:1 RCT which compared bilateral ...
5
Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
... Alpha-1 antitrypsin deficiency (AATD) is a congenital autosomical codominant condition characterized by low plasma levels of alpha-1 antitrypsin (AAT) in the blood and ...
6
Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values
... AATD: Alpha-1 antitrypsin deficiency; COPD: Chronic obstructive pulmonary disease; CT: Computed tomography; DLCO: Diffusing capacity for carbon monoxide; EMA: European medicines agency; FDA: ...
10
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
... Alpha-1-antitrypsin deficiency with its many genotypes and its manifestation in various organs is rarely observed in daily clinical practice and is frequently not diagnosed or ...to ...
9
Alpha-1 antitrypsin deficiency: outstanding questions and future directions
... Despite these recommendations AATD is a largely under-recognised condition [35]. Patients experience long diagnostic delays (up to 5.6 years) and often visit several doctors before the definitive diagnosis is reached ...
15
Alternative transcripts of the SERPINA1 gene in alpha 1 antitrypsin deficiency
... Expression of different transcripts in tissues and periph- eral blood white cells was evaluated by conventional reverse transcription polymerase chain reaction ampli- fication (RT-PCR). Total RNA extraction was per- ...
11
<p>New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency</p>
... IV self-administration has been utilized in other therapy areas such as hereditary angioedema, and has demonstrated bene fi ts in terms of reducing time off work, and reducing healthcare visits and episodes of ...
11
Heterozygous Alpha-1-Antitrypsin Deficiency and Respiratory Function in Children
... However, when subjects were matched to avoid other genetic or environmental biases, statistically significant differences in pulmonary function were noted in Pi type MZ children compared[r] ...
12
Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
... the deficiency should be undertaken from diagnosis over at least 2–3 years assessing all aspects of physiological health status, not only FEV1, to determine stability or instability before the decision about ...
9
Association of IREB2 and CHRNA3polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency
... We have identified that the chromosome 15q25 region likely contains at least one potential modifier gene of COPD phenotypes in individuals with severe AAT defi- ciency. The association may be due to smoking beha- vior, ...
7
The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency
... Materials and methods: Serum and exhaled breath condensate were collected from individuals with protease inhibitor phenotype ZZ AAT deficiency-related emphysema (n = 12) on the first, third, and seventh day after ...
10
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
... chest radiography in early disease may be normal or may show minimal change. This has led to interest in detecting disease earlier and permitting greater quantitative assessment through computed tomography (CT) scans of ...
9
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
... Bronchial secretions of chronic obstructive pulmonary disease (COPD) patients with A1AT deficiency were observed to have increased levels of IL-8 and, in particular leukotriene B 4 (LTB 4 ). LTB 4 and IL-8 are ...
14
The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency
... Four hundred and twenty four unrelated Caucasian sub- jects from the UK national registry for AATD were studied. Ethical approval was given by the local ethics committee. All patients had a serum ...
8